Zanidatamab Outcomes and Lived Experiences in Advanced HER2+ GEA
Zanidatamab Outcomes and Lived Experiences in Advanced HER2+ GEA
Not yet recruiting · NCT07780968 · Registry updated 2026-10-02Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Zanidatamab Outcomes and Lived Experiences in Advanced HER2+ GEA | Digestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Neoplasms by Site, digestive system disorder, digestive system neoplasm, esophageal cancer, esophageal disorder, gastric cancer, gastric neoplasm, gastroesophageal cancer, neoplasm, stomach disorder | Not yet recruiting | Not stated | 2026-10-02 | NCT07780968 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Jazz Pharmaceuticals | 60 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| UCI Health - Chao Family Comprehensive Cancer Center | Orange | United States | 1 |
| University of Texas - MD Anderson Cancer Center Gastrointestinal Cancer Center | Houston | United States | 1 |